Postcholecystectomy syndrome: a new look at the old problem and the possibilities of pathogenetic therapy.

Author:

Zvyagintseva T.D., ,Chernobay A.I.,Yaroshenko A.V.,Oparin A.G., , ,

Abstract

In the article, from the modern standpoint, the pathogenetic and clinical characteristics of PCS as a dysfunction of the sphincter of Oddi are given, the mechanisms for the development of this pathology, the principles of therapy with the inclusion of the drug Rowachol, containing six plant monoterpenes, are disclosed. The materials of our own observations of the treatment of patients with Oddi sphincter dysfunction after laparoscopic cholecystectomy by Rowachol are presented. Anti-inflammatory, litholytic, hypocholesterolemic and pleiotropic effects of Rowachol have been proved. Rowachol should be positioned as a pathogenetic natural remedy for treatment of Oddi sphincter dysfunction and biliary sludge in patients undergoing cholecystectomy for cholelithiasis.

Publisher

National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)

Reference32 articles.

1. 1. Bordin DS, Dubcova EA, Selezneva JeJa. Jeffektivnost' i bezopasnost' razlichnyh doz gemikronoma u bol'nyh, perenesshih holecistjektomiju. Jeffektivnaja farmakoterapija. 2021;3:34-39. Russian

2. 2. Bystrovskaja E.V. Postholecistjektomicheskij sindrom: patogeneticheskie i terapevticheskie aspekty problem. remedium.ru. Russian

3. 3. Bueverov AO. Disfunkcija sfinktera Oddi v postholecistjektomicheskom periode. Medicinskij sovet. 2020;15:90-95. doi: 10.21518/2079-701X2020-15-90-95. Russian

4. 4. Zvjaginceva TD, Chernobaj AI. Patogeneticheskaja korrekcija biliarnoj boli pri postholecistjektomicheskom sindrome i disfunkcii sfinktera Oddi. Suchasna gastroenterologіja. 2012;6(68):81-92. Russian

5. 5. Zviahintseva TD, Serhiienko OI, Chernobai AI. Funktsionalni zakhvoriuvannia biliarnoi systemy. Funktsionalni zakhvoriuvannia orhaniv travlennia. Kharkiv: Tochka; 2010. Р 35-70. Ukrainian

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3